181 related articles for article (PubMed ID: 2014852)
1. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study).
Homesley HD; Bundy BN; Sedlis A; Yordan E; Berek JS; Jahshan A; Mortel R
Am J Obstet Gynecol; 1991 Apr; 164(4):997-1003; discussion 1003-4. PubMed ID: 2014852
[TBL] [Abstract][Full Text] [Related]
2. Staging for vulvar cancer.
Hacker NF; Barlow EL
Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):802-11. PubMed ID: 25842047
[TBL] [Abstract][Full Text] [Related]
3. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
Fonseca-Moutinho JA; Coelho MC; Silva DP
J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors of vulvar cancer].
Sago N; Nakao Y; Iwasaka T
Gan To Kagaku Ryoho; 2006 Dec; 33(13):1991-7. PubMed ID: 17197741
[TBL] [Abstract][Full Text] [Related]
5. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival.
van der Velden J; van Lindert AC; Lammes FB; ten Kate FJ; Sie-Go DM; Oosting H; Heintz AP
Cancer; 1995 Jun; 75(12):2885-90. PubMed ID: 7773938
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study).
Homesley HD; Bundy BN; Sedlis A; Yordan E; Berek JS; Jahshan A; Mortel R
Gynecol Oncol; 1993 Jun; 49(3):279-83. PubMed ID: 8314530
[TBL] [Abstract][Full Text] [Related]
7. Risk of occult inguinofemoral lymph node metastasis from squamous carcinoma of the vulva.
Gonzalez Bosquet J; Kinney WK; Russell AH; Gaffey TA; Magrina JF; Podratz KC
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):419-24. PubMed ID: 12957253
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: revisiting the FIGO staging system.
Baiocchi G; Silva Cestari FM; Rocha RM; Lavorato-Rocha A; Maia BM; Cestari LA; Kumagai LY; Faloppa CC; Fukazawa EM; Badiglian-Filho L; Sant'ana Rodrigues I; Soares FA
Eur J Surg Oncol; 2013 Jul; 39(7):780-5. PubMed ID: 23518307
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical versus surgical staging systems in vulvar cancer.
Shanbour KA; Mannel RS; Morris PC; Yadack A; Walker JL
Obstet Gynecol; 1992 Dec; 80(6):927-30. PubMed ID: 1448261
[TBL] [Abstract][Full Text] [Related]
10. Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer.
van Beekhuizen HJ; Auzin M; van den Einden LC; de Hullu JA; van der Velden J; Wildhagen MF; van Doorn HC
Int J Gynecol Cancer; 2014 May; 24(4):773-8. PubMed ID: 24662136
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.
Mahner S; Jueckstock J; Hilpert F; Neuser P; Harter P; de Gregorio N; Hasenburg A; Sehouli J; Habermann A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Thiel F; Mustea A; Meier W; du Bois A; Griebel LF; Woelber L;
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25618900
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
[TBL] [Abstract][Full Text] [Related]
13. Positive groin lymph nodes in superficial squamous cell vulvar cancer. A Gynecologic Oncology Group Study.
Sedlis A; Homesley H; Bundy BN; Marshall R; Yordan E; Hacker N; Lee JH; Whitney C
Am J Obstet Gynecol; 1987 May; 156(5):1159-64. PubMed ID: 3578430
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO.
Origoni M; Sideri M; Garsia S; Carinelli SG; Ferrari AG
Gynecol Oncol; 1992 Jun; 45(3):313-6. PubMed ID: 1612509
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review.
Te Grootenhuis NC; Pouwer AW; de Bock GH; Hollema H; Bulten J; van der Zee AGJ; de Hullu JA; Oonk MHM
Gynecol Oncol; 2018 Mar; 148(3):622-631. PubMed ID: 29137809
[TBL] [Abstract][Full Text] [Related]
16. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
[TBL] [Abstract][Full Text] [Related]
17. Patterns of inguinal groin metastases in squamous cell carcinoma of the vulva.
Gonzalez Bosquet J; Magrina JF; Magtibay PM; Gaffey TA; Cha SS; Jones MB; Podratz KC; Cliby WA
Gynecol Oncol; 2007 Jun; 105(3):742-6. PubMed ID: 17379281
[TBL] [Abstract][Full Text] [Related]
18. Midline involvement as a risk factor for vulvar cancer recurrence.
Stankevica J; Macuks R; Baidekalna I; Donina S
Asian Pac J Cancer Prev; 2012; 13(10):5237-40. PubMed ID: 23244142
[TBL] [Abstract][Full Text] [Related]
19. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients.
Burger MP; Hollema H; Emanuels AG; Krans M; Pras E; Bouma J
Gynecol Oncol; 1995 Jun; 57(3):327-34. PubMed ID: 7774836
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of prognostic indicators in squamous carcinoma of the vulva including nuclear DNA content.
Ballouk F; Ambros RA; Malfetano JH; Ross JS
Mod Pathol; 1993 May; 6(3):371-5. PubMed ID: 8346186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
